Marc Theoret

31PUBLICATIONS
185CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 24, 2025
US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia.

Nina Kim, E Dianne Pulte, Lori A Ehrlich

|Aug 19, 2025
FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy.

Cara A Rabik, Shu Wang, Ritu Chadda

|Jul 24, 2025
Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology.

Laura A Levit, Mirat Shah, Mark J Ratain

|Jul 23, 2025
FDA Approval Summary: Lifileucel for Unresectable or Metastatic Melanoma Previously Treated with an Anti-PD-1-Based Immunotherapy.

Lianne Hu, Chaohong Fan, Peter Bross

|Jul 15, 2025
FDA Approval Summary: Lisocabtagene Maraleucel for Relapsed or Refractory Follicular Lymphoma.

Kristen Britton, Upendra Mahat, Nicholas C Richardson

|Jul 01, 2025
FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation.

Ashley C Woods, E Dianne Pulte, Xin Wang

Pageof 6

Frequent Collaborators

15 joint publications

Richard Pazdur

12 joint publications

R Angelo de Claro

9 joint publications

Jonathon Vallejo

8 joint publications

Kelly J Norsworthy